Clinical Trial Update: Veliparib, Cisplatin, and Vinorelbine Ditartrate in Treating Patients With Recurrent and/or Metastatic Breast Cancer [Phase 1]

View source ↗

Summary

Phase 1 trial evaluating the combination of veliparib with cisplatin and vinorelbine ditartrate in patients with recurrent and/or metastatic breast cancer; incl…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Brca1-associated Breast Cancer
• Brca2-associated Breast Cancer
• Breast Cancer
• Estrogen Receptor Negative Breast Cancer
• Male Breast Cancer
• Triple-negative Breast Cancer

Drugs mentioned

• CISPLATIN (cisplatin)
• Veliparib (ABT-888) (veliparib)
• Vinorelbine ditartrate (vinorelbine ditartrate)

Snippet

Sponsor: University of Washington | Conditions: Estrogen Receptor-negative Breast Cancer, HER2-negative Breast Cancer | Phase 1 | Status: COMPLETED